Anti-CD20 therapy for severe and refractory lupus nephritis (RLN).: An original preliminary study

被引：0
|
作者：
Abud-Mendoza, C
Irazoque, F
Andrade, L
Cuevas-Orta, E
Valdés, RV
Santillán, E
Navarro-Cano, G
Saldaña-Barnard, M
González-Amaro, R
Borjas, JA
Aranda, F
机构：
[1] Univ Autonoma San Luis Potosi, Cent Hosp, Unidad Reg Reumatol & Osteoporosis, San Luis Potosi, SLP, Mexico
[2] Univ Autonoma San Luis Potosi, Cent Hosp, Fac Med, San Luis Potosi, SLP, Mexico
[3] Hosp 20 Noviembre, ISSSTE, Mexico City, DF, Mexico
来源：
JOURNAL OF RHEUMATOLOGY | 2006年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：427 / 428
页数：2
相关论文
共 50 条
  • [1] Anti-CD20 antibody treatment in refractory Class IV lupus nephritis
    Carroll, Robert P.
    Brown, Fiona
    Kerr, Peter G.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (01) : 291 - 293
  • [2] Long-term efficacy of anti-CD20 antibodies in refractory lupus nephritis
    Alejandro Arce-Salinas, C.
    Rodriguez-Garcia, Felipe
    Ivan Gomez-Vargas, J.
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (05) : 1245 - 1249
  • [3] Long-term efficacy of anti-CD20 antibodies in refractory lupus nephritis
    C Alejandro Arce-Salinas
    Felipe Rodríguez-García
    J Iván Gómez-Vargas
    Rheumatology International, 2012, 32 : 1245 - 1249
  • [4] A pilot study of rituximab (anti-CD20) for refractory systemic lupus erythematosus
    Tanaka, Y.
    Tokunaga, M.
    Nawata, M.
    Nakayamada, S.
    Sawamukai, N.
    Saito, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 360 - 361
  • [5] Anti-CD20 therapy for inducing and maintaining remission in refractory systemic lupus erythematosus
    Chehab, G.
    Sander, O.
    Fischer-Betz, R.
    Schneider, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 (04): : 328 - +
  • [6] Anti-CD20 in lupus
    Isenberg, DA
    Leandro, MJ
    Ehrenstein, MR
    Edwards, JCW
    Manson, J
    Cambridge, G
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 27 - 28
  • [7] Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis
    Chiarenza, Decimo Silvio
    Mancini, Raul
    Bigatti, Carolina
    Caridi, Gianluca
    Consolaro, Alessandro
    Natoli, Valentina
    Mortari, Gabriele
    Kajana, Xhuliana
    Lugani, Francesca
    Gattorno, Marco
    Ghiggeri, Gian Marco
    La Porta, Edoardo
    Gaggero, Gabriele
    Verrina, Enrico E.
    Angeletti, Andrea
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [8] Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients
    Garcia-Carrasco, M.
    Mendoza-Pinto, C.
    Sandoval-Cruz, M.
    Soto-Vega, E.
    Beltran-Castillo, A.
    Jimenez-Hernandez, M.
    Graillet, D.
    Gonzalez, L.
    Rojas-Rodriguez, J.
    Pineda-Almazana, A.
    Zamudio-Huerta, L.
    Lopez-Colombo, A.
    LUPUS, 2010, 19 (02) : 213 - 219
  • [9] Anti-CD20 therapy in systemic lupus erythematosus: A step closer to the clinic
    Silverman, GJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (02): : 371 - 377
  • [10] Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)
    Morrison, LH
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (05) : 817 - 819
12345